0A23 Stock Overview Provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Phreesia, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Phreesia Historical stock prices Current Share Price US$25.14 52 Week High US$28.74 52 Week Low US$17.28 Beta 0.99 1 Month Change 28.46% 3 Month Change 8.81% 1 Year Change 11.78% 3 Year Change -38.66% 5 Year Change n/a Change since IPO -59.69%
Recent News & Updates
New minor risk - Profitability Dec 10
Forecast to breakeven in 2027 Dec 10
Phreesia, Inc. Provides Earnings Guidance for the Fiscal Year 2026 Dec 10
Third quarter 2025 earnings released: US$0.25 loss per share (vs US$0.58 loss in 3Q 2024) Dec 10
Phreesia, Inc. to Report Q3, 2025 Results on Dec 09, 2024 Nov 01
Second quarter 2025 earnings released: US$0.31 loss per share (vs US$0.68 loss in 2Q 2024) Sep 06 See more updates
New minor risk - Profitability Dec 10
Forecast to breakeven in 2027 Dec 10
Phreesia, Inc. Provides Earnings Guidance for the Fiscal Year 2026 Dec 10
Third quarter 2025 earnings released: US$0.25 loss per share (vs US$0.58 loss in 3Q 2024) Dec 10
Phreesia, Inc. to Report Q3, 2025 Results on Dec 09, 2024 Nov 01
Second quarter 2025 earnings released: US$0.31 loss per share (vs US$0.68 loss in 2Q 2024) Sep 06
Phreesia, Inc. Maintains Revenue Guidance for the Fiscal Year 2025 Sep 05
General Counsel & Secretary recently sold US$367k worth of stock Aug 30
Phreesia, Inc. to Report Q2, 2025 Results on Sep 04, 2024 Aug 01
New major risk - Share price stability Jul 17
New major risk - Financial position Jun 04
Phreesia, Inc. Updates Earnings Guidance for the Year 2025 Jun 01
Phreesia, Inc. Updates Earnings Guidance for the Year 2025 May 31
Phreesia, Inc., Annual General Meeting, Jun 26, 2024 May 17
Phreesia, Inc. to Report Q1, 2025 Results on May 30, 2024 May 01
Chief Financial Officer recently sold US$176k worth of stock Apr 11
Phreesia Appoints Jack Callahan as Chief Technology Officer Mar 19
Full year 2024 earnings released: US$2.51 loss per share (vs US$3.36 loss in FY 2023) Mar 15
Phreesia, Inc. to Report Q4, 2024 Results on Mar 14, 2024 Feb 06
Co-Founder recently sold US$1.6m worth of stock Jan 19
Third quarter 2024 earnings released: US$0.58 loss per share (vs US$0.76 loss in 3Q 2023) Dec 06
Phreesia, Inc. Provides Earnings Guidance for the Fiscal Year 2024 and Fiscal Year 2025 Dec 06
Phreesia, Inc. to Report Q3, 2024 Results on Dec 05, 2023 Nov 02
Co-Founder recently sold US$133k worth of stock Sep 20
Phreesia, Inc. Reaffirms Earnings Guidance for the Full Fiscal Year Ending January 31, 2024 and Fiscal Year 2025 Sep 08
Phreesia, Inc. Reaffirms Earnings Guidance for the Full Fiscal Year Ending January 31, 2024 and Fiscal Year 2025 Sep 07
Second quarter 2024 earnings released: US$0.68 loss per share (vs US$0.89 loss in 2Q 2023) Sep 07
Insufficient new directors Sep 07
New major risk - Revenue and earnings growth Aug 28
Insufficient new directors Aug 15
Phreesia, Inc. to Report Q2, 2024 Results on Sep 06, 2023 Aug 03
Phreesia, Inc. Appoints Lisa Egbuonu-Davis to Board of Directors Jul 14
Insufficient new directors Jul 06
Phreesia, Inc.(NYSE:PHR) dropped from Russell Small Cap Comp Value Index Jun 25
First quarter 2024 earnings released: US$0.70 loss per share (vs US$0.99 loss in 1Q 2023) Jun 02
Insufficient new directors May 26
Phreesia, Inc., Annual General Meeting, Jun 28, 2023 May 19
Insufficient new directors Apr 25
Full year 2023 earnings released: US$3.36 loss per share (vs US$2.37 loss in FY 2022) Mar 24
Insufficient new directors Feb 21
Phreesia, Inc. to Report Q4, 2023 Results on Mar 22, 2023 Feb 03
Third quarter 2023 earnings released: US$0.76 loss per share (vs US$0.71 loss in 3Q 2022) Dec 09
Phreesia, Inc. Provides Revenue Guidance for the Fiscal Year 2023 Dec 09
Insufficient new directors Dec 01
Phreesia, Inc. to Report Q3, 2023 Results on Dec 08, 2022 Oct 29
Second quarter 2023 earnings released Sep 08
Insufficient new directors Sep 08
Phreesia, Inc. Updates Revenue Outlook for Fiscal Year 2023 Sep 08
Insufficient new directors Aug 08
Phreesia, Inc. to Report Q2, 2023 Results on Sep 07, 2022 Jul 30
Insufficient new directors Jun 29
Phreesia, Inc. Provides Earning Guidance for Fiscal 2023 and 2025 Jun 03
Phreesia, Inc., Annual General Meeting, Jun 30, 2022 May 18
Phreesia, Inc. to Report Q1, 2023 Results on Jun 02, 2022 May 02
Full year 2022 earnings released: US$2.37 loss per share (vs US$0.69 loss in FY 2021) Apr 01 Phreesia, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023 Mar 31
Phreesia, Inc. to Report Q4, 2022 Results on Mar 30, 2022 Mar 01
Phreesia, Inc. (NYSE:PHR) acquired Insignia Health, LLC from University of Oregon and others. Dec 15
Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat Dec 09 Phreesia, Inc. Provides Earnings Guidance for the Fiscal Year 2023
Second quarter 2022 earnings released: US$0.48 loss per share (vs US$0.17 loss in 2Q 2021) Sep 03
Phreesia, Inc. Provides Revenue Guidance for the Fiscal Year 2022 Sep 02
Independent Director recently sold US$300k worth of stock Jun 27
First quarter 2022 earnings released: US$0.24 loss per share (vs US$0.16 loss in 1Q 2021) Jun 06
Phreesia, Inc. Provides Revenue Guidance for the Fiscal Year 2022 Jun 04
Full year 2021 earnings released: US$0.69 loss per share (vs US$4.50 loss in FY 2020) Apr 02
Phreesia, Inc. Provides Earnings Guidance for the Year Ending January 31, 2022 Apr 01
Phreesia, Inc. to Report Q4, 2021 Results on Mar 30, 2021 Feb 26
Insider recently sold US$330k worth of stock Jan 23 Shareholder Returns 0A23 GB Healthcare Services GB Market 7D 0.3% -5.6% -2.6% 1Y 11.8% 13.9% 2.4%
See full shareholder returns
Return vs Market: 0A23 exceeded the UK Market which returned 2.4% over the past year.
Price Volatility Is 0A23's price volatile compared to industry and market? 0A23 volatility 0A23 Average Weekly Movement 9.4% Healthcare Services Industry Average Movement 6.1% Market Average Movement 4.8% 10% most volatile stocks in GB Market 10.6% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: 0A23's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: 0A23's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients’ mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks.
Show more Phreesia, Inc. Fundamentals Summary How do Phreesia's earnings and revenue compare to its market cap? 0A23 fundamental statistics Market cap US$1.46b Earnings (TTM ) -US$82.78m Revenue (TTM ) US$405.14m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0A23 income statement (TTM ) Revenue US$405.14m Cost of Revenue US$133.14m Gross Profit US$272.00m Other Expenses US$354.78m Earnings -US$82.78m
Last Reported Earnings
Oct 31, 2024
Earnings per share (EPS) -1.42 Gross Margin 67.14% Net Profit Margin -20.43% Debt/Equity Ratio 0.9%
How did 0A23 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 15:50 End of Day Share Price 2024/12/20 00:00 Earnings 2024/10/31 Annual Earnings 2024/01/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Phreesia, Inc. is covered by 24 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Joseph Vruwink Baird Zhilin Long Berenberg Richard Close Canaccord Genuity
Show 21 more analysts 